Drug Profile
Hib conjugate vaccine - Masoondarou Biopharma
Alternative Names: MAS-HibVACLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Masoondarou Biopharma
- Class Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilus infections
Most Recent Events
- 01 Apr 2013 Launched for Haemophilus infections in Iran (IM)
- 20 Apr 2012 Phase-III clinical trials in Haemophilus infections in Iran (IM)